Clinical Trial Update: A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients [Phase 2]

View source ↗

Summary

Phase 2 study of ICA-105665 in photosensitive epilepsy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photosensitive Epilepsy

Drugs mentioned

• ICA-105665

Snippet

Sponsor: Pfizer | Conditions: Epilepsy | Phase 2 | Status: TERMINATED